1-6 of 6
Sandrine Geffroy, PHD
Close
Sort by
Journal Articles

Clofarabine-Based Consolidation Improves Relapse-Free Survival of Patients with Acute Myeloid Leukemia with Complex or Micro-Complex Karyotype: Results from the Randomized ALFA-0702 Study

Laurène Fenwarth, MSc, MD, Nicolas Duployez, PharmD, PhD, Xavier Thomas, MD, Nicolas Boissel, MD PhD, Sandrine Geffroy, PhD, Alice Marceau-Renaut, PharmD, Denis Caillot, MD, Emmanuel Raffoux, MD, Emilie Lemasle, MD, Jean-Pierre Marolleau, MD PhD, Céline Berthon, MD PhD, Meyling H. Cheok, MSPharm, PhD, Pauline Peyrouze, Arnaud Pigneux, MD PhD, Norbert Vey, Karine Celli-Lebras, CRA, Christine Terré, PharmD, PhD, Claude Preudhomme, PharmD, PhD, Herve Dombret, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 465.
https://doi.org/10.1182/blood.V130.Suppl_1.465.465
Published: 2017
Journal Articles

Molecular Profiling Defines Distinct Prognostic Subgroups in Chilhood Acute Myeloid Leukemia: A Report from the French ELAM02 Study Group

Alice Marceau-Renaut, PharmD, Nicolas Duployez, PharmD, PhD, Benoit Ducourneau, PharmD, Myriam Labopin, MD, Arnaud Petit, MD PhD, Alexandra Rousseau, Sandrine Geffroy, PhD, Maxime Bucci, Wendy Cuccuini, Odile Fenneteau, MD, Brigitte Nelken, MD, Stéphane Ducassou, MD, Virginie Gandemer, MDPhD, Thierry Leblanc, MD, Gerard Michel, MD, Yves Bertrand, MD, Andre Baruchel, MD, Guy Leverger, MD PhD, Claude Preudhomme, PharmD, PhD, Hélène Lapillonne, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 403.
https://doi.org/10.1182/blood.V130.Suppl_1.403.403
Published: 2017
Journal Articles

TP53 Mutation in Waldenstrom Macroglobulinemia

Stephanie Poulain, Christophe Roumier, MD, Elisabeth Bertrand, Aline Renneville, MD, Sabine Tricot, Aurelie Caillault Venet, Sandrine Geffroy, PhD, Morgan Nudel, Charles Herbaux, MD, Stéphanie Guidez, Claude Preudhomme, MD PhD, Xavier Leleu
Journal: Blood
Blood (2016) 128 (22): 4092.
https://doi.org/10.1182/blood.V128.22.4092.4092
Published: 2016
Journal Articles

Deletion of the Tumor Suppressor Gene NF1 Is Found In 3.5% of 485 De Novo Adult Myeloid Leukemia and Is Correlated with Unfavourable Cytogenetic: On Behalf of the ALFA Group

Elise Labis, PhD, Catherine Roche-Lestienne, PhD, Olivier Nibourel, Nicolas Boissel, MD, PhD, Christophe Roumier, PhD, Christine Terre, PhD, Christine Perot, PhD, Virginie Eclache, PhD, Nathalie Gachard, PhD, Isabelle Tigaud, PhD, Ghislaine Plessis, PhD, Wendy Cuccuini, PhD, Sandrine Geffroy, PhD, Nathalie Helevaut, PhD, Sabine Quief, PhD, Martin Figeac, PhD, Aline Renneville, PhD, Meyling Cheok, Bruno Quesnel, MD, PhD, Herve Dombret, MD, Claude Preudhomme, PhD
Journal: Blood
Blood (2010) 116 (21): 4171.
https://doi.org/10.1182/blood.V116.21.4171.4171
Published: 2010
Journal Articles

RUNX1 DNA-Binding Mutations and RUNX1-PRDM16 Cryptic Fusion in BCR/ABL+ Leukemias Are Frequently Associated with Secondary Trisomy 21 and May Contribute to Clonal Evolution and Imatinib Resistance.

Catherine Roche-Lestienne, PhD, Laureline Deluche, MD, Selim Corm, MD, Isabelle Tigaud, MD, Sami Joha, PhD, Nathalie Philippe, PhD, Sandrine Geffroy, PhD, Jean-Luc Lai, PhD, Franck Nicolini, MD, PhD, Claude Preudhomme, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 2786.
https://doi.org/10.1182/blood.V110.11.2786.2786
Published: 2007
Journal Articles

Molecular Characterization of Genomic Structural Alterations through CGH Arrays in Acute Myeloid Leukemia with Normal Cytogenetic Findings.

Christophe Roumier, MD, Sandrine Geffroy, PHD, Olivier Nibourel, MD, Sabine Quief, Celine Villenet, Aline Reneville, MD, Valeria Biggio, PHD, Jean-Luc Laï, PHD, Jean-Pierre Kerckaert, PHD, Claude Preudhomme, MD/PHD
Journal: Blood
Blood (2006) 108 (11): 105.
https://doi.org/10.1182/blood.V108.11.105.105
Published: 2006